These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 17656824)
41. Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy. Bacskai BJ; Kajdasz ST; McLellan ME; Games D; Seubert P; Schenk D; Hyman BT J Neurosci; 2002 Sep; 22(18):7873-8. PubMed ID: 12223540 [TBL] [Abstract][Full Text] [Related]
42. Differential Phagocytic Properties of CD45 Rangaraju S; Raza SA; Li NX; Betarbet R; Dammer EB; Duong D; Lah JJ; Seyfried NT; Levey AI Front Immunol; 2018; 9():405. PubMed ID: 29552013 [TBL] [Abstract][Full Text] [Related]
43. Immune defects in Alzheimer's disease: new medications development. Cashman JR; Ghirmai S; Abel KJ; Fiala M BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S13. PubMed ID: 19090986 [TBL] [Abstract][Full Text] [Related]
44. Peripheral Tumor Necrosis Factor-Alpha (TNF-α) Modulates Amyloid Pathology by Regulating Blood-Derived Immune Cells and Glial Response in the Brain of AD/TNF Transgenic Mice. Paouri E; Tzara O; Kartalou GI; Zenelak S; Georgopoulos S J Neurosci; 2017 May; 37(20):5155-5171. PubMed ID: 28442538 [TBL] [Abstract][Full Text] [Related]
45. Changes in phagocytosis and potassium channel activity in microglia of 5xFAD mice indicate alterations in purinergic signaling in a mouse model of Alzheimer's disease. Wendt S; Maricos M; Vana N; Meyer N; Guneykaya D; Semtner M; Kettenmann H Neurobiol Aging; 2017 Oct; 58():41-53. PubMed ID: 28697378 [TBL] [Abstract][Full Text] [Related]
46. Biomarkers of inflammation and amyloid-beta phagocytosis in patients at risk of Alzheimer disease. Fiala M; Veerhuis R Exp Gerontol; 2010 Jan; 45(1):57-63. PubMed ID: 19699791 [TBL] [Abstract][Full Text] [Related]
48. Effect of Lipopolysaccharide Derived from Pantoea agglomerans on the Phagocytic Activity of Amyloid β by Primary Murine Microglial Cells. Kobayashi Y; Inagawa H; Kohchi C; Okazaki K; Zhang R; Soma G Anticancer Res; 2016 Jul; 36(7):3693-8. PubMed ID: 27354642 [TBL] [Abstract][Full Text] [Related]
49. Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Rogers J; Lue LF Neurochem Int; 2001; 39(5-6):333-40. PubMed ID: 11578768 [TBL] [Abstract][Full Text] [Related]
50. The role of microglia in antibody-mediated clearance of amyloid-beta from the brain. Morgan D CNS Neurol Disord Drug Targets; 2009 Mar; 8(1):7-15. PubMed ID: 19275633 [TBL] [Abstract][Full Text] [Related]
51. Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits. Scholtzova H; Do E; Dhakal S; Sun Y; Liu S; Mehta PD; Wisniewski T J Neurosci; 2017 Jan; 37(4):936-959. PubMed ID: 28123027 [TBL] [Abstract][Full Text] [Related]
52. N-truncation and pyroglutaminylation enhances the opsonizing capacity of Aβ-peptides and facilitates phagocytosis by macrophages and microglia. Condic M; Oberstein TJ; Herrmann M; Reimann MC; Kornhuber J; Maler JM; Spitzer P Brain Behav Immun; 2014 Oct; 41():116-25. PubMed ID: 24876064 [TBL] [Abstract][Full Text] [Related]
53. The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer's disease: neuropathological, epidemiological and genetic evidence. Eikelenboom P; Veerhuis R; van Exel E; Hoozemans JJ; Rozemuller AJ; van Gool WA Curr Alzheimer Res; 2011 Mar; 8(2):142-50. PubMed ID: 21345167 [TBL] [Abstract][Full Text] [Related]
54. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease. Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087 [TBL] [Abstract][Full Text] [Related]
55. Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease. Kawanishi S; Takata K; Itezono S; Nagayama H; Konoya S; Chisaki Y; Toda Y; Nakata S; Yano Y; Kitamura Y; Ashihara E J Alzheimers Dis; 2018; 64(2):563-585. PubMed ID: 29914020 [TBL] [Abstract][Full Text] [Related]
56. Microglial overexpression of the M-CSF receptor augments phagocytosis of opsonized Abeta. Mitrasinovic OM; Murphy GM Neurobiol Aging; 2003 Oct; 24(6):807-15. PubMed ID: 12927763 [TBL] [Abstract][Full Text] [Related]
57. Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids. Fiala M; Kooij G; Wagner K; Hammock B; Pellegrini M FASEB J; 2017 Aug; 31(8):3229-3239. PubMed ID: 28420693 [TBL] [Abstract][Full Text] [Related]
59. Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease. Jana M; Palencia CA; Pahan K J Immunol; 2008 Nov; 181(10):7254-62. PubMed ID: 18981147 [TBL] [Abstract][Full Text] [Related]